Reach Us +1-947-333-4405


Joel Barratt | OMICS International
ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Publons
  • Euro Pub
Share This Page

Joel Barratt

Joel Barratt University of Technology, Sydney, Broadway, Australia.


Dr Joel Barratt completed undergraduate studies (B. Biotech, first class Honours) at UTS in 2007. His honours project involved a study on the molecular prevalence the parasite Neospora caninum, in feral rodents. Upon completion he employed by UTS as a research assistant on a project entitled ‘Diagnosis of Gastrointestinal Parasites’.He completed  PhD in 2009, which involved a study on the genetics of the human parasite, Dientamoeba fragilis. This research generated several peer reviewed publications and a patent and was ranked among the top 6 submitted at UTS in 2013, which is qualified for inclusion on the 2013 Chancellor’s List.He completed graduation studies in Research Commercialisation. He had contributed to 19 peer reviewed journal articles, with several others in press or under peer review and contributed to 15 national/international conference abstracts. He was recently volunteered to entertain at the 2014 Ultimo Science Festival and at a Sydney Nerd Nite. He had appllied for a prestigious Chancellor’s Postdoctoral Fellowship at UTS to complete a project entitled “Laboratory validation of vaccine candidates for leishmaniasis predicted using a novel in silico pipeline based on machine learning algorithms” and it was successful and he currently hold this appointment. He is a member of  iThree Institute, Australian Society for Parasitology, Sydney Parasitology Research Hub. 

Research Interest

 Antiprotozoal activity, parasitic infections, protozoal infections treatment with dry plant extracts, diagnosis of gastro intestinal parasites, genetics of human parasite dientamoeba fragilis.


Global Speakers in the subject

Global Experts in the subject